Saturday, August 4, 2018

New Novartis CEO feels heat on U.S. generics business

ZURICH (Reuters) – Swiss drugmaker Novartis' first quarterly results under new CEO Vas Narasimhan have been marred by a prized psoriasis treatment that disappointed and a sharp slump in sales by its U.S. generics unit.

 

copyright © 2018



from New Novartis CEO feels heat on U.S. generics business
via New Novartis CEO feels heat on U.S. generics business August 04, 2018 at 10:22PM
RSS Feed

Regional Justice Center, Las Vegas Nevada Consumer Credit Counseling Service

IFTTT

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.